174 related articles for article (PubMed ID: 35652077)
41. CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up.
Berg IJ; Semb AG; van der Heijde D; Kvien TK; Olsen IC; Dagfinrud H; Provan SA
Ann Rheum Dis; 2015 Aug; 74(8):1562-6. PubMed ID: 25795906
[TBL] [Abstract][Full Text] [Related]
42. Investigation of changes in ankylosing spondylitis disease activity through 2021 COVID-19 wave in Taiwan by using electronic medical record management system.
Huang PJ; Chen YW; Yen TH; Liu YT; Lin SP; Chen HH
Sci Rep; 2023 Jan; 13(1):349. PubMed ID: 36611127
[TBL] [Abstract][Full Text] [Related]
43. The association of neuropathic pain and disease activity, functional level, and quality of life in patients with ankylosing spondylitis: a cross-sectional study.
Geler-Külcü D; Batıbay S; Öztürk G; Mesci N
Turk J Med Sci; 2018 Apr; 48(2):257-265. PubMed ID: 29714437
[TBL] [Abstract][Full Text] [Related]
44. Reviewing Disease Activity Indices in Spondyloarthritis From the Sex Perspective: A Systematic Review and Metaanalysis.
Blasco-Blasco M; Castrejón I; Jovaní V; Pascual E; Ruiz-Cantero MT
J Rheumatol; 2021 Sep; 48(9):1395-1404. PubMed ID: 33795327
[TBL] [Abstract][Full Text] [Related]
45. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
[TBL] [Abstract][Full Text] [Related]
46. Longitudinal Association Between Trabecular Bone Loss and Disease Activity in Axial Spondyloarthritis: A 4-year Prospective Study.
Kang KY; Ju JH; Park SH; Hong YS
J Rheumatol; 2020 Sep; 47(9):1330-1337. PubMed ID: 31732556
[TBL] [Abstract][Full Text] [Related]
47. Ankylosing Spondylitis patients with Type D personality have worse clinical status.
Erkol İnal E; Demirci K; Doğru A; Şahin M
Mod Rheumatol; 2016; 26(1):138-45. PubMed ID: 26011439
[TBL] [Abstract][Full Text] [Related]
48. Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis.
Aydin SZ; Can M; Atagunduz P; Direskeneli H
Clin Exp Rheumatol; 2010; 28(5):752-5. PubMed ID: 20863448
[TBL] [Abstract][Full Text] [Related]
49. [A study on calculating the ankylosing spondylitis disease activity score according to the C-reactive protein level].
Ji X; Du J; Zhu J; Huang F; Zhang J
Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):206-10. PubMed ID: 26926373
[TBL] [Abstract][Full Text] [Related]
50. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis.
van der Heijde D; Lie E; Kvien TK; Sieper J; Van den Bosch F; Listing J; Braun J; Landewé R;
Ann Rheum Dis; 2009 Dec; 68(12):1811-8. PubMed ID: 19060001
[TBL] [Abstract][Full Text] [Related]
51. Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry.
Akgul O; Bodur H; Ataman S; Yurdakul FG; Capkin E; Gurer G; Sezer I; Duruoz MT; Melikoglu MA; Cay HF; Rezvani A; Yagci I; Gogus F; Kamanli A; Cevik R
Rheumatol Int; 2020 Nov; 40(11):1793-1801. PubMed ID: 32814986
[TBL] [Abstract][Full Text] [Related]
52. Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable.
Ortolan A; Ramiro S; van Gaalen F; Kvien TK; Landewe RBM; Machado PM; Ruyssen-Witrand A; van Tubergen A; Bastiaenen C; van der Heijde D
Rheumatology (Oxford); 2021 Feb; 60(2):638-648. PubMed ID: 32572483
[TBL] [Abstract][Full Text] [Related]
53. Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study.
Arends S; Brouwer E; van der Veer E; Groen H; Leijsma MK; Houtman PM; Th A Jansen TL; Kallenberg CG; Spoorenberg A
Arthritis Res Ther; 2011 Jun; 13(3):R94. PubMed ID: 21689401
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study.
Mease PJ; Gladman DD; Poddubnyy D; Chakravarty SD; Shawi M; Kollmeier AP; Xu XL; Xu S; Deodhar A; Baraliakos X
Rheumatol Ther; 2023 Dec; 10(6):1637-1653. PubMed ID: 37819505
[TBL] [Abstract][Full Text] [Related]
55. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
[TBL] [Abstract][Full Text] [Related]
56. Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry.
Tužil J; Mlčoch T; Jirčíková J; Závada J; Nekvindová L; Svoboda M; Uher M; Křístková Z; Vencovský J; Pavelka K; Doležal T
Expert Opin Biol Ther; 2020 Feb; 20(2):183-192. PubMed ID: 31736377
[No Abstract] [Full Text] [Related]
57. Comparison of ankylosing spondylitis patients with and without fibromyalgia syndrome according to the disease activation scores and response to treatment.
Durmaz Y; İlhanlı İ
Turk J Phys Med Rehabil; 2021 Dec; 67(4):509-517. PubMed ID: 35141491
[TBL] [Abstract][Full Text] [Related]
58. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.
Lukas C; Landewé R; Sieper J; Dougados M; Davis J; Braun J; van der Linden S; van der Heijde D;
Ann Rheum Dis; 2009 Jan; 68(1):18-24. PubMed ID: 18625618
[TBL] [Abstract][Full Text] [Related]
59. Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain.
Benavent D; Franco-Gómez K; Plasencia-Rodriguez C; Novella-Navarro M; Bogas P; Nieto R; Monjo I; Nuño L; Villalba A; Peiteado D; Balsa A; Navarro-Compán V
BMJ Open; 2022 Apr; 12(4):e057850. PubMed ID: 35487753
[TBL] [Abstract][Full Text] [Related]
60. Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial.
Şilte Karamanlioğlu D; Aktas I; Ozkan FU; Kaysin M; Girgin N
Rheumatol Int; 2016 May; 36(5):653-61. PubMed ID: 26923690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
